Kristian Steen Frederiksen, MD, PhD, FEBN, Danish Dementia Research Centre, Rigshospitalet, Copenhagen, Denmark, outlines the results of an online survey performed among members of the European Alzheimer’s Disease Consortium (EADC) on biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment (MCI). This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).
